Skip to main content

Table 1 Identification of differentially abundant metabolites in LC–MS and GC–MS in Iran vs. China comparison

From: Metabolomics characterization of two saffron from Iran and China using GC–MS and LC–MS methods

Platform

Name

Class I

Fold_Change

p-value

Regulation

 

(3S,13Z,16Z)-3-amino-4-hydroxy-2-methyldocosa-13,16-dien-5-one

Lipids

6.77E−02

5.22E−08

Down

 

Cafestol

Terpenoids

1.68E−01

3.34E−07

Down

 

4-Hydroxyquinoline

Alkaloids

4.87E−01

6.38E−07

Down

 

N-carboxy-N-(2-oxo-2-phenylethyl)-L-alanine

Amino acids and derivatives

2.89E−01

1.22E−06

Down

 

4-[(2 s,3r,4r)-4-(3,4-dimethoxyphenyl)-4-hydroxy-2,3-dimethylbutyl]-2-methoxyphenol

Lignans and Coumarins

4.05E−01

1.53E−06

Down

 

3,4-Dihydro-4-(4'-hydroxyphenyl)-5,7-dihydroxycoumarin

Lignans and Coumarins

4.35E−01

1.97E−06

Down

 

4-hydroxy-3(3-methylbut-3-en-2-yl) benzaldehyde

Others

4.55E−01

2.22E−06

Down

 

linolenoylethanolamine

Lipids

3.87E−01

2.90E−06

Down

 

rhodomollein XI

Terpenoids

3.26E + 00

2.94E−06

Up

 

Tababiphenyl C

Others

3.18E + 00

3.11E−06

Down

UPLC-MS/MS

Tyr-Gly

Amino acids and derivatives

4.81E−01

3.19E−06

Down

 

Luteolin-6-C-(2''-glucuronyl)glucoside

Flavonoids

5.72E−02

4.50E−06

Down

 

Butylphthalide

Others

4.41E−01

5.41E−06

Down

 

β-Nicotinamide mononucleotide

Nucleotides and derivatives

2.13E−01

6.07E−06

Down

 

inumakiol G

Terpenoids

2.67E−01

6.81E−06

Down

 

14,15-Dehydrocrepenynic acid

Lipids

4.94E−01

7.92E−06

Down

 

DL-Glyceric Acid

Organic acids

3.75E−01

9.91E−06

Down

 

Uridine 5'-diphosphate

Nucleotides and derivatives

2.69E + 00

1.42E−05

Up

 

2-Methoxy-6-undecyl-1,4-benzoquinone

Quinones

2.86E−01

1.42E−05

Down

 

N-Benzoyl-(2R,3S)-3-phenylisoserine

Amino acids and derivatives

4.38E−01

1.48E−05

Down

 

Valproic Acid

Acid

3.73E−01

3.07E−06

Down

 

o-Xylene

Aromatics

3.81E−01

8.76E−05

Down

 

Acetic acid, 2-phenylethyl ester

Ester

2.28E−01

1.58E−04

Down

 

Pyrazine, 2-ethyl-3,5-dimethyl-

Heterocyclic compound

3.27E−01

1.83E−04

Down

 

trans-Linalool oxide (furanoid)

Heterocyclic compound

2.93E + 00

2.27E−04

Up

GC–MS

D-Limonene

Terpenoids

2.68E−01

2.91E−04

Down

 

1H-Pyrazole-1-carboximidamide, 3,5-dimethyl-

Heterocyclic compound

2.47E + 00

3.31E−04

Up

 

2-Acetyl-3,4,5,6-tetrahydropyridine

Heterocyclic compound

4.12E−01

3.54E−04

Down

 

cis-3-Hexenyl cis-3-hexenoate

Ester

3.55E−01

3.81E−04

Down

 

3-Hexene, 1-(1-ethoxyethoxy)-, (Z)-

Aldehyde

4.25E−01

4.84E−04

Down

 

2,4-Hexadienal, (E,E)-

Aldehyde

5.00E−01

6.02E−04

Down

 

Bicyclo[3.1.0]hexane, 4-methylene-1-(1-methylethyl)-

Terpenoids

7.97E−02

6.69E−04

Down

 

p-Cymene

Aromatics

3.23E−04

7.40E−04

Down

 

1H-Pyrazole

Heterocyclic compound

4.85E−01

7.42E−04

Down

 

2-Nonenenitrile

Nitrogen compounds

2.76E−01

7.71E−04

Down

 

Dodecane, 4,6-dimethyl-

Hydrocarbons

2.95E−01

7.94E−04

Down

 

Pyrazine, 3,5-diethyl-2-methyl-

Heterocyclic compound

4.13E−01

9.12E−04

Down

 

Benzene, 1-methoxy-4-propyl-

Aromatics

4.75E−01

9.30E−04

Down

 

Cyclohexanone

Ketone

4.54E−01

1.13E−03

Down

 

Acetic acid, heptyl ester

Ester

4.21E−01

1.13E−03

Down

  1. The upregulated sample was the metabolites that were increased in the China compared with Iran. The downregulated sample was the metabolites that were decreased in the China compared with Iran